These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28490582)

  • 1. Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity.
    Britt WJ
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal Immunity and the Natural History of Congenital Human Cytomegalovirus Infection.
    Britt WJ
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30081449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy.
    Lilleri D; Gerna G
    Rev Med Virol; 2017 Mar; 27(2):. PubMed ID: 28008685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
    Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.
    Plachter B
    Med Microbiol Immunol; 2016 Dec; 205(6):537-547. PubMed ID: 27519596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.
    Schleiss MR; Stroup G; Pogorzelski K; McGregor A
    Vaccine; 2006 Sep; 24(37-39):6175-86. PubMed ID: 16879902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy.
    Britt W
    Med Microbiol Immunol; 2015 Jun; 204(3):263-71. PubMed ID: 25764180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.
    Permar SR; Schleiss MR; Plotkin SA
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural vs vaccine-acquired immunity to cytomegalovirus.
    Plotkin SA
    JAMA; 2003 Oct; 290(13):1709; author reply 1709. PubMed ID: 14519704
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytomegalovirus infection in pregnancy].
    Pusztai R
    Orv Hetil; 2009 May; 150(21):963-8. PubMed ID: 19443304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal immune correlates of protection against placental transmission of cytomegalovirus.
    Itell HL; Nelson CS; Martinez DR; Permar SR
    Placenta; 2017 Dec; 60 Suppl 1(Suppl 1):S73-S79. PubMed ID: 28456432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection.
    Burny W; Liesnard C; Donner C; Marchant A
    Expert Rev Anti Infect Ther; 2004 Dec; 2(6):881-94. PubMed ID: 15566332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.
    Weisblum Y; Oiknine-Djian E; Zakay-Rones Z; Vorontsov O; Haimov-Kochman R; Nevo Y; Stockheim D; Yagel S; Panet A; Wolf DG
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a formula for an effective CMV vaccine?
    Plotkin SA
    J Clin Virol; 2002 Aug; 25 Suppl 2():S13-21. PubMed ID: 12361753
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission.
    Fan Q; Nelson CS; Bialas KM; Chiuppesi F; Amos J; Gurley TC; Marshall DJ; Eudailey J; Heimsath H; Himes J; Deshpande A; Walter MR; Wussow F; Diamond DJ; Barry PA; Moody MA; Kaur A; Permar SR
    Clin Vaccine Immunol; 2017 May; 24(5):. PubMed ID: 28298291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease.
    Fu TM; An Z; Wang D
    Vaccine; 2014 May; 32(22):2525-33. PubMed ID: 24681264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
    Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
    Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of human cytomegalovirus (HCMV)-specific antibody in HCMV-infected pregnant women.
    Revello MG; Fornara C; Arossa A; Zelini P; Lilleri D
    Early Hum Dev; 2014 Mar; 90 Suppl 1():S32-4. PubMed ID: 24709453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.
    Boppana SB; Britt WJ
    Methods Mol Biol; 2021; 2244():403-463. PubMed ID: 33555597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.
    Schleiss MR; Bourne N; Stroup G; Bravo FJ; Jensen NJ; Bernstein DI
    J Infect Dis; 2004 Apr; 189(8):1374-81. PubMed ID: 15073673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.